Topics

Glioblastoma | Treatment | Chemotherapy | Temozolomide | Stupp Protocol

Home > Publications > Topics > Glioblastoma > Treatment > Chemotherapy > Temozolomide > Stupp Protocol

Lee S, Kim M.
Analysis of Patients with Glioblastoma Treated with Standard 6-Week Chemoradiation Followed by Temozolomide: Treatment Outcomes and Prognostic Factors.
Medicina (Kaunas). 2025 Feb 21;61(3):376. doi: 10.3390/medicina61030376. PMID: 40142187. Observational study. ˍ

Sharpe MA, Baskin AM, Teh BS, Butler EB, Baskin DS.
Optimizing the Stupp protocol for treatment of glioblastoma: eliminating age bias, enhancing treatment timing, use of stereotactically-guided sequential boost, and dexamethasone dosing.
J Neurooncol. 2026 Jul 3;178(3):88. doi: 10.1007/s11060-026-05685-2. PMID: 42397615. ˍ

Ng IB, Jani RH, Goyal A, Pickles A, Prabhu VC, Wainwright DA, Barton K, Thakkar JP.
Single Institution Retrospective Study to Determine Time to First True Progression in MGMT-Methylated Glioblastoma Patients Who Received Standard of Care.
J Clin Med. 2026 Jun 29;15(13):5073. doi: 10.3390/jcm15135073. PMID: 42452534. ˍ